Overexpression of high mobility group box 1 (HMGB1) resulted in poor prognosis in human bladder urothelial carcinoma [143] and patients after radical prostatectomy in prostate cancer [136,137], while its overexpression in gastric adenocarcinomas yields favorable prognosis [144]. This evidence concerns the gene HMGB1 and prostate carcinoma.